Atorvastatin

CAS 134523-00-5 6 current records 6 historicalSmall Molecule

Who holds supplier records for Atorvastatin? 6 organisations hold a current record for Atorvastatin: an active US FDA Type II Drug Master File. A further 6 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3), Canada (1) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Atorvastatin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/atorvastatin

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Atorvastatin expires 7 Jun 2037. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Atorvastatin. Country is the organisation's recorded country, not necessarily the manufacturing site.

India3Canada1China1Country not recorded for 1
  • Apotex Inc.
    Active DMF 21574 · latest filing Apr 2008
    Canada
  • Cadila Pharmaceuticals Limited
    Active DMF 28122 · latest filing Apr 2014
    India Company GMP cert on record
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 19997 · latest filing Nov 2006
    India Company GMP cert on record
  • RAKS PHARMA PVT LTD
    Active DMF 26084 · latest filing May 2012
    India
  • ZHEJIANG LEPU PHARMACEUTICAL CO., LTD.
    Active DMF 26022 · latest filing Apr 2012
    China
  • ZHEJIANG NEO DANKONG PHARMACEUTICAL CO LTD
    Active DMF 20535 · latest filing May 2007
Need Atorvastatin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (6)

Organisations whose Type II DMFs for Atorvastatin are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • DSM SINOCHEM PHARMACEUTICALS NETHERLANDS BV
    Inactive DMF 23052 · filed Aug 2009
  • India · Inactive DMF 22728 · filed Apr 2009
  • India · Inactive DMF 20207 · filed Jan 2007
  • APOTEX PHARMACHEM INC
    Inactive DMF 20117 · filed Dec 2006
  • India · Inactive DMF 18402 · filed Jun 2005
  • RANBAXY LABORATORIES LTD
    Inactive DMF 17484 · filed Jun 2004

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (97 listed products contain Atorvastatin). The latest listed patent expires 7 Jun 2037. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Atorvastatin is a statin medication used to prevent cardiovascular disease and manage abnormal lipid levels. It works by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol.

Chemical identity

IUPAC name
(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
Canonical SMILES
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
InChIKey
XUKUURHRXDUEBC-MNKXOHRSSA-N
Synonyms
Lipitor, Atorvastatin calcium, Atorvastatin calcium trihydrate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
HMG-CoA Reductase Inhibitor
Mechanism of action
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Therapeutic areas

Cardiovascular DiseasesLipid Metabolism DisordersAtherosclerosis

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Atorvastatin?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Atorvastatin: Apotex Inc. (Canada), Cadila Pharmaceuticals Limited (India), Dr. Reddy's Laboratories Ltd. (India), RAKS PHARMA PVT LTD (India), ZHEJIANG LEPU PHARMACEUTICAL CO., LTD. (China) and ZHEJIANG NEO DANKONG PHARMACEUTICAL CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Atorvastatin Drug Master Files are active?

Apotex Inc. (DMF 21574), Cadila Pharmaceuticals Limited (DMF 28122), Dr. Reddy's Laboratories Ltd. (DMF 19997), RAKS PHARMA PVT LTD (DMF 26084), ZHEJIANG LEPU PHARMACEUTICAL CO., LTD. (DMF 26022) and ZHEJIANG NEO DANKONG PHARMACEUTICAL CO LTD (DMF 20535). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Atorvastatin records mean?

6 organisations have only inactive Type II DMFs for Atorvastatin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Atorvastatin?

Yes. The latest patent listed for an approved US product containing Atorvastatin expires 7 Jun 2037, across 97 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Atorvastatin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Atorvastatin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.